Category Archives: Biochemistry

Biochemistry

Kashmir’s least affected district has higher sero-prevalence of COVID19 than all-India average: Survey – Greater Kashmir

A survey has shown higher than national average sero-prevalence of COVID19 in Kashmirs least affected district, Pulwama, raising questions about the prevalence of the viral infection in other districts here.

A sero-prevalence survey carried out in May in district Pulwama by Government Medical College (GMC) Srinagar on behalf of Indian Council of Medical Research (ICMR) has shown some surprising results. As per department of social and preventive medicine of GMC Srinagar, that carried out the survey, the sero-prevalence of COVID19 was 2 percent in Pulwama. ICMR has said that in non-containment zones, and low prevalence districts, of which Pulwama was a part when the study started, the prevalence was 0.73 percent.

Sero-prevalence involves testing for IgG levels in an individuals blood, and tells whether they have been infected in the recent past with SARS CoV-2. It also helps in gauging the degree of protection they have achieved in terms of antibody response to the virus. The ICMR nationwide study covered 83 districts and hotspots with 26400 population covered.

Dr Saleem Khan, head department of social and preventive medicine at GMC Srinagar said that the results obtained from testing in Pulwama were suggestive of the prevalence of COVID19 in a particular community at a point dating back to two weeks prior to sampling. The samples we took on 28 May would tell us how many people were infected, among those we tested, two weeks prior, he said.

Pulwama was among the lowest prevalence districts of Kashmir around the time of the survey and had been selected based on this. Dr Khan said similar surveys in other districts and other populations could help in understanding the spread of infection.

Dr Khan said sero-prevalence was a measure of bodys immune response to COVID19 and it could also help in gauging whether antibodies provided some kind of protection against future infections.

He said sero-prevalence of COVID19 in healthcare professionals project started on Sunday. We will be testing around 3000 samples of healthcare professionals in Srinagar district as a collaborative research project by Departments of Community Medicine and Biochemistry.

We shall be testing doctors, nursing paramedic, support staff of various Associated Hospitals of GMC Srinagar and various hospitals and health centers of Directorate of Health Services under CMO Srinagar, he said.

A handout by the department said the blood samples would be collected and processed by Department of Biochemistry GMC Srinagar through ARCHITECT immunoassay analyzer which has been shown to have 100 percent sensitivity and specificity after 17 days of SARS CoV-2 exposure and clinical symptoms.

In addition, a sero-prevalence study in general population was also in pipeline.

Principal GMC Srinagar, Prof Samia Rashid said the sero-prevalence was an important measurement and the surveys will help in understanding the spread of COVID19 better. Healthcare professionals are a high risk group and we are trying to test as many of them to safeguard lives, she said.

Go here to see the original:
Kashmir's least affected district has higher sero-prevalence of COVID19 than all-India average: Survey - Greater Kashmir

Biochemistry

The music of the Nagyvary and Stradivari violins – San Diego Jewish World

SAN DIEGO Joseph Nagyvary, the brilliant Hungarian-born Professor of Biochemistry from Texas A & M, had just finished delivering a lecture at Louisiana State University in Shreveport. His topic was his research into the chemical properties of Stradivari violins. This prompted one of his colleagues to suggest that he contact my sister, concert violinist, Zina Schiff, who was living in Shreveport at the time. Nagyvary immediately phoned Zina, they arranged to meet, and that encounter spawned performances, recordings, and a seminal TV appearance.

Soon after they met, Zina traveled to College Station to perform a recital on a Nagyvary violin.The Biochemistry professor was a pioneer in the investigation of the chemical make-up, the preservatives, and the varnish of the woods used for the famous Cremona-made violins.The violin Zina played was the result of his discoveries. Supported by a grant from the state of Texas, Nagyvary invited Zina to accompany him at his lectures to demonstrate the fine qualities of his violins. One of her recitals was for the National Conference of the American Chemical Society.

Zina played the Sibelius Violin Concerto with the La Jolla Symphony, Thomas Nee, conducting, on a Nagyvary violin. That performance was filmed and became part of a PBS NOVA program, What Is Music. For her two debut CDs with the Israel Philharmonic Orchestra, Bach/Vivaldi and The Lark Ascending, Zina played on a Nagyvary violin. In honor of Nagyvarys work and the 125th Anniversary ofTexas A & M University, Zina was invited to present a recital at the Bush Presidential Library in College Station, where she alternated, playing on a 1697 Stradivarius and a 1991 Nagyvarius. Texas A & M also released a 2001 recording, The Stradivarius Puzzle, in which some of the selections are on the Stradivarius and others are on a Nagyvarius.

The Stradivarius Puzzlewas actually recorded in San Diego with Mary Barranger, pianist of the San Diego Symphony and the San Diego Chamber Orchestra, as Zinas fine collaborator. It includes the Adagio and Fugue from Sonata #1 for unaccompanied violin by Johann Sebastian Bach (1685-1750), Suite Italienne by Igor Stravinsky (1882-1971), arranged forviolin and piano by Samuel Dushkin (1891-1976), and Suite Reb Mendele by Simon Sargon (1938-).

Zina became acquainted with Simon Sargons music when he sent her Suite Reb Mendele for perusal. He was the Professor of Composition at Southern Methodist University and Music Director at Temple Emanu-El in Dallas,Texas. Zina performed Sargons Suite Reb Mendele with David Amos and the Tifereth Israel Community Orchestra. She has also playedthe violin-piano version of the work in recitals, as heard on thisrecording.

The three excepts from The Stradivarius Puzzle are: Fugue from the Sonata #1 by Bach (track 2); Supplication (track 10) and Freilach (track 12)from Suite Reb Mendele by Sargon.

In the liner notes, Joseph Nagyvary wrote: Our violin, made in 1991, has a similar combination of focus and brilliance as a typical Stradivarius. One should not forget that the tonal beauty of both violins is also due to the exquisite artistry of Zina Schiff.

*Eileen Wingard, a retired violinist with the San Diego Symphony Orchestra, is a freelance writer specializing in coverage of the arts. She may be contacted via eileen.wingard@sdjewishworld.com

Visit link:
The music of the Nagyvary and Stradivari violins - San Diego Jewish World

Biochemistry

Predicting the evolution of COVID-19 to help manage future outbreaks – UBC Faculty of Medicine – UBC Faculty of Medicine

As the world prepares for future waves of COVID-19, the ability to predict mutations in the novel coronavirus even before they emerge will be essential to stopping future outbreaks.

Dr. Natalie Strynadka

UBC faculty of medicines Dr. Robert Brunham and Dr. Natalie Strynadka, together with the faculty of sciences Steven Plotkinalong with a team of commercial and academic collaboratorsare one step closer to achieving this thanks to a $1.8 million grant from the Digital Technology Supercluster COVID-19 Program, which aims to find solutions to urgent health care needs across Canada arising from COVID-19.

The project, Predicting the Evolution of COVID-19, brings together experts in artificial intelligence, computer modelling and structural biology to predict changes to SARS-CoV-2, the virus that causes COVID-19. The findings will inform the early design of effective tests, therapies and vaccines, allowing public health systems globally to prepare and ideally prevent future pandemics caused by evolving strains of the virus.

For the first six-month phase of the project, Dr. Strynadkas lab is working to generate atomic resolution experimental datausing a cutting edge biophysical toolbox including x-ray crystallography and single particle cryo-electron microscopythat will in turn help train the computational algorithms to optimally predict future mutations of the virus

We are incredibly excited about this project, and grateful to the Digital Technology Supercluster for supporting our work, says Dr. Strynadka, a professor in the faculty of medicines department of biochemistry and molecular biology. Our goal is to harness powerful computational methods to predict mutations in the SARS-CoV-2 virus. We are working to create algorithms that will hopefully keep us a step ahead of the virus and give us the ability to know where future mutations might arise.

Our goal is to harness powerful computational methods to predict mutations in the SARS-CoV-2 virus. We are working to create algorithms that will hopefully keep us a step ahead of the virus and give us the ability to know where future mutations might arise. Dr. Natalie Strynadka

Dr. Brunham, a professor in the faculty of medicines division of infectious diseases and head of the Vaccine Research Laboratory at the BC Centre for Disease Control who was involved in responding to the SARS outbreak in 2003, is lending his expertise in vaccine development.

Dr. Robert Brunham

We believe the coronavirus spike protein may very well be the basis for a vaccine for this virus, says Brunham. This work will be tremendously important in anticipating whether the virus will mutate to escape immunity generated by the vaccine.

As part of the project, Plotkins lab is designing a universal antibody therapy that the virus cant easily evade through mutation.

Given past outbreaks such as SARS and MERS, which were also caused by coronaviruses, there is no reason to assume that another pandemic wouldnt happen again, says Plotkin, a professor in the department of physics and astronomy and has held a Canada Research Chair in Theoretical Molecular Biophysics. This is a problem that is not going to go away on its own, so we have to be forward-thinking in finding solutions for it.

The Predicting the Evolution of COVID-19 project is led by Terramera, a Vancouver-based company that fuses science, nature and artificial intelligence to transform how food is grown and the economics of agriculture. Collaborating partners include D-Wave, Menten AI, Microsoft, and ProMIS Neurosciences.

See the article here:
Predicting the evolution of COVID-19 to help manage future outbreaks - UBC Faculty of Medicine - UBC Faculty of Medicine

Biochemistry

Researchers are developing portable device to detect the presence of PFAS in water – News-Medical.Net

Potentially harmful man-made chemicals used in firefighting foam and consumer products have contaminated groundwater and even private wells near military, industrial and disposal sites across the country-; including Joe Foss Field and Ellsworth Air Force Base in South Dakota.

Currently, scientists must take water and soil samples from the sites to the lab and use expensive instruments to detect the presence of per- and poly-fluoroalkyl substances, known as PFAS, said South Dakota State University chemistry and biochemistry professor Brian Logue.

"There currently is not a good way to take that technology to the field."

Logue and research scientist Randy Jackson of Seacoast Science, Inc. are developing a portable device to detect the presence of PFAS in water, sediment, and soil through a two-year, $300,000 Phase II Small Business Innovation and Research grant from the Environmental Protection Agency.

This is part of the agency's efforts to help states and communities identify and address PFAS contamination and thereby protect the nation's drinking water.

PFAS is a family of more than 3,000 chemicals used to make water- and stain-resistant fabrics, carpets, and clothing as well as nonstick cookware. They are in paints, cleaning products, some food packaging, and firefighting agents.

Some are also present in coatings for electronic components and solar panels as well as in medical devices.

The researchers are expanding the technology they developed for a portable cyanide detection device. That project was part of Jackson's doctoral work, which he completed under Logue's tutelage.

PFAS has been called "forever chemicals" because they are very stable-; they persist both in the environment and in the human body.

For most organic compounds, there are bacteria or oxidative or hydrologic chemical reactions that degrade them into less toxic compounds.However, PFAS is very difficult to degrade, so they stick around for a long time unless you actively try to degrade them."

Brian Logue, Professor of Chemistry and Biochemistry, South Dakota State University

"They are engineered to break down slowly with a half-life in water of more than 92 years," Jackson said.

"Their high water solubility makes them especially dangerous they can enter and be transported by groundwater into the drinking water supply."

Ellsworth Air Force Base near Rapid City is one of the EPA's Superfund cleanup sites, due to PFAS contamination from the foam used to extinguish aircraft fires.

In 2017, the U.S. Air Force reported that PFAS groundwater contamination had spread beyond the base into local private drinking water wells.

Last June, the City of Sioux Falls filed suit in U.S. District Court against a number of chemical companies, including 3M and DuPont, because PFAS has contaminated surface and groundwater, soil, and sediment in the portion of Joe Foss Field leased to the South Dakota Air National Guard.

Human exposure can occur through contaminated water, soil, and air. In 2007, the Centers for Disease Control and Prevention, which monitors human exposure to environmental chemicals, found 98% of Americans have detectable levels of PFAS in their blood.

The substances also accumulate in the liver and kidneys.

Scientists have just begun studying their impact on human health; however, changes in liver, thyroid, and pancreas function and hormone levels occur in animals exposed to high levels of PFAS, according to the Agency for Toxic Substances and Disease Registry.

In Phase I, which was completed last year, the researchers showed they can measure/detect PFAS in water.

"We came up with the idea to degrade PFAS to smaller components that are not as difficult to analyze, then isolate them and detect them fluorometrically like we detect cyanide in our lab," Logue explained. However, he noted, though the concept is similar, "all the details are quite a bit different."

Degrading the PFAS into smaller components is relatively easy, but selectively isolating these components from the matrix is challenging, he explained.

Furthermore, the researchers had to synthesize chemicals that would react, or fluoresce, in the presence of the smaller components.

"We found a good fluorometric agent in Phase I, did some degradations, and got some good results," Logue said. Two doctoral students are also working on the project. During Phase II, the researchers will put the proof of concept into practice.

"Now it is time to take the core technology and create a sensor to do this analysis," he added.

This will involve optimizing the process, determining exactly which chemistry to use and the time required to detect PFAS.

"We've focused so far on water, which is the easiest matrix," Logue said. "Once the sensor works well with water, there are ways to prepare soil samples to use that same technology."

Based on the near-real-time analysis, the scientists will then know whether the site warrants further assessment.

In addition, Logue sees the possibility of further applications for the sensor because industries use similar compounds.

The rest is here:
Researchers are developing portable device to detect the presence of PFAS in water - News-Medical.Net

Biochemistry

Global Automatic Biochemistry Analyzers Market 2020 (COVID-19) Impact Analysis: Business Trends, Growth Insight, Statistics And Forecast to 2025 – 3rd…

Global Automatic Biochemistry Analyzers Market Growth 2020-2025 combines the essentials, definitions, categorization, and analysis of significant features about the market. The report covers global market top players, types, applications, patterns, and size. The vital information featured in this report makes the research document a handy resource along with in the form of graphs and figures. The research analyzes various market dynamics, the quickest, and the slowest market segments. This document has all the useful essential information, for example, the financial strategies, applications, future growth, development, and advancement components of the global Automatic Biochemistry Analyzers market.

The comprehensive data comprises analysis on size and patterns, inhibitors, elements, drivers, openings and difficulties, condition and arrangement, cost outline, porters five power investigation, and key organizations profiles including business review and improvement. Data pertaining to the companys product range, product features, and individual product applications have been accentuated in the global Automatic Biochemistry Analyzers report. In addition, information regarding the growth prospects for the market in every specified region is also highlighted in the report.

NOTE: This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-dept analysis of Automatic Biochemistry Analyzers market.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketandresearch.biz/sample-request/137014

Competitive Rivalry:

The report company profiles study the various companies operating in the global Automatic Biochemistry Analyzers market. It evaluates the financial outlooks of these companies, their research and development statuses, and their expansion strategies for the coming years. Key companies operating in the market are taking efforts to deliver upgraded products in the market and they are engaged in research activities, innovations, product developments, and technology adoptions. The report studies their strategic efforts such as mergers, acquisitions, ventures, and amalgamations.

The report demonstrates all the important data related to the prominent players covering Roche, Horiba Medical, Danaher, Abbott, Hitachi, Siemens Healthcare, KHB, Mindray Medical, Abaxis, Thermo Scientific, Urit, Randox Laboratories, Tecom Science, ELITech, Senlo, Sunostik, Adaltis, Sysmex, Gaomi Caihong, Dirui, Rayto, .

Consumption, production, capacity, market share, growth rate, and prices are included for each product type segment of global Automatic Biochemistry Analyzers market: Floor-standing, Bench-top,

Consumption, market share and growth rate for each application segment of Automatic Biochemistry Analyzers market: Primary Hospital, Provincial Hospital, Prefectural Hospital,

On the basis of the region, the market has been analyzed in Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries) along with its regional development status.

Moreover, in the global Automatic Biochemistry Analyzers market report, each regional market is extensively studied on the basis of import and export, key players, revenue, and production. This study document will help you in finding any price ranges, pricing issues, and determination of price fluctuation of products in the industry.

ACCESS FULL REPORT: https://www.marketandresearch.biz/report/137014/global-automatic-biochemistry-analyzers-market-growth-2020-2025

Aim Of The Automatic Biochemistry Analyzers Market Report:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketandresearch.biz

Read the rest here:
Global Automatic Biochemistry Analyzers Market 2020 (COVID-19) Impact Analysis: Business Trends, Growth Insight, Statistics And Forecast to 2025 - 3rd...

Biochemistry

COVID-19 Impact on Global Biochemistry Analyzer Industry 2020: Industry Trends, Size, Applications, SWOT Analysis by Top Key Players and Forecast…

Biochemistry Analyzer IndustryReport is designed to provide Industry Experts and Investors with detail overview of Biochemistry Analyzer Industry report, which will help them to take decisions with respect to Key Players, Regions, Manufacturers, Types and Trend etc.

This report gives a detail insight for a period of 2018-2025 Research Report. The market size estimations have been provided in terms of value (USD million).

Get Sample Copy of this Report at https://www.orianresearch.com/request-sample/590363

TheGlobal Biochemistry Analyzer Marketis expected to grow USD XX Million by 2025 at a CAGR of around 5.9% during the forecast period, 2018-2025. Biochemistry analyser can chemicals in biological samples. These analyzers focuses on analytes such as electrolytes, drugs of abuse, specific proteins, enzyme, and metabolite tests for cardiac, liver, and renal function.

Top Key Players Analyzed in Global Biochemistry Analyzer Market are Siemens AG Thermo Fisher Scientific, Inc. Randox Laboratories Ltd. Abbott, Danaher Corporation F.Hoffman-La Roche Ltd. Meril, Hologic Inc. Beckman Coulter Inc. Horiba Medical

The market size estimations have been provided in terms of value (USD million). The global Biochemistry Analyzer industry report also identifies major market players and provides analysis in terms of company overview, Financials, products & services, market trends, recent developments and growth strategies.

Regionally, North America, Latin America, Europe, Asia Pacific, And the Middle East & Africa constitute the key market segments.

Complete report on Biochemistry Analyzer Industry spread across 121 pages, profiling 8 companies and supported with tables and figures. For more details Enquire @https://www.orianresearch.com/enquiry-before-buying/590363

Theglobal Biochemistry Analyzer marketis anticipated to show significant growth during the forecast period. This growth can be attributed to rising incidence of diseases and rapidly growing demand for diagnostic tests. Due to a increase in the disposable income, the number of people with insurance has also increased, giving them accessibility to private labs that have high-end diagnostic instruments. However, high cost of diagnostic tests is key factor projected to curb the market growth over the forecast period.

Biochemistry analyzer have wide applications in Clinical Diagnostics, Drug Development Applications, Bioreactor By Product Detection and Others. clinical diagnostics segment was the leading segment and it accounted for largest share of total revenue generated in 2017. The drug development applications segment is forecast to be the second most lucrative segment in the global biochemistry analyzers market

Key Benefit Of This Report: Global, Regional, Country, Application, and TECHNOLOGY Market Size and Forecast from 2014-2025 Provide attractive market segments and associated growth opportunities Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies Identification of key companies that can influence this market on a global and regional scale Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies Detailed insights on emerging regions, product & application, and competitive landscape with qualitative and quantitative information and facts

Get Direct Copy of this Report @https://www.orianresearch.com/checkout/590363

In terms of revene, North America held large chunk of market share in 2017 on account of presence of developed healthcare infrastructure. In 2017, Europe was the second largest regional market in terms of revenue. Asia pacific is expected to witness rapid growth within the forecast period owing to increasing demand from China, Japan, and India.

Major Points Covered in Table of Contents:1 Executive Summary2 Methodology And Market Scope3 Infiniband Market Industry Outlook4 Biochemistry Analyzer Market Type Outlook5 Biochemistry Analyzer Market Application Outlook6 Biochemistry Analyzer Market Regional Outlook7 Competitive Landscape

Customization Service of the Report:

Orian Research provides customisation of reports as per your need. This report can be personalised to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:

Orian Researchis one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President Global Sales & Partner RelationsOrian Research ConsultantsUS: +1 (832) 380-8827 | UK: +44 0161-818-8027Email:[emailprotected]

Website:www.orianresearch.com/

Follow this link:
COVID-19 Impact on Global Biochemistry Analyzer Industry 2020: Industry Trends, Size, Applications, SWOT Analysis by Top Key Players and Forecast...

Biochemistry

NMSU’s Breland Hall evolves over more than 60 years – New Mexico State University NewsCenter

Facebook Twitter LinkedIn Google+ Pinterest

Built in 1956, Breland Hall, named after Rufus Galloway Breland, is home to the College of Arts and Sciences, which includes 26 departments. Originally built as mens dormitories, Breland Hall accommodated 300 men and offered modern facilities such as a television and recreational lounge along with laundry facilities. Breland Hall served as a dorm for two decades before being repurposed into an academic building for the College of Arts and Sciences, which provides the core liberal arts education at NMSU. The departments for humanities and social sciences are mainly located at Breland Hall along with the offices of the dean, while other areas such as astronomy, biology, geology, chemistry and biochemistry are housed in separate facilities on campus with both classrooms and laboratories.

About Rufus Galloway Breland

Rufus Galloway Breland was born in Maryland in December 1906. Breland came to NMSU in 1925 as an English professor. He taught English literature, public speaking, and vocabulary. Although he was a strict professor, he was beloved by his students. After teaching for four years, he served as department head until his death in 1940. In February 1956, the Board of Regents voted to name the new mens dormitory in honor of Rufus Breland. The dormitory was officially dedicated during homecoming in 1958 when Brelands brother from New York City could be there for the ceremony.

Architectural History

Breland Hall was part of the new wave of architecture after the university outgrew architect Henry C. Trosts master plan that was developed in 1907 for thirteen buildings positioned around "The Horseshoe." His plan was followed faithfully until the growth of the school and its programs required expansion beyond the horseshoe.

The architectural style adopted by Trost and McGhee was still utilized to some degree by other architects following World War II and well into the 1950s. Breland Hall was one of the buildings that included Trosts Spanish Renaissance style that featured hipped roofs with clay tiles and domed towers.

Santa Fe architect Leo J. Wolgamood worked as a draftsman under many renowned architects around the world and served in the Civil Engineer Corps of the U.S. Navy before becoming a registered architect in New Mexico where he formed a partnership with Alfred R. Millington in Santa Fe.

In the mid-1950s, Wolgamood designed several school buildings across New Mexico. At NMSU, Wolgamood designed Breland Hall, along with Gardiner Hall and the Chemistry Building. His buildings reflected the trend toward Regional Modernism by incorporating Modernist styling, such as large glass curtain walls at the main entries, with touches of Spanish Renaissance Revival styling, such as red tile roofing, that emulated the work of previous architects Trost and Percey McGhee.

In October of 1952, the Board of Regents applied for $1 million in loan assistance for the construction of Breland Hall and Hamiel Hall. Construction began in 1954 and Breland Hall was completed by September 1, 1956 at a cost of $705,666.

Renovations over the years

Breland Hall has undergone several renovations and improvements over more than 60 years. The most significant project was in 1976 when the facility was remodeled, changing its use from a dormitory to accommodate the College of Arts and Sciences offices, classrooms, and laboratories. The renovation cost $1.9 million.

NMSU History Archives

Read more here:
NMSU's Breland Hall evolves over more than 60 years - New Mexico State University NewsCenter

Biochemistry

Meet the maker: EPM talks to CN Bio’s Jean-Pierre Joubert – EPM Magazine

EPM speaks to Jean-Pierre Joubert, product manager at CN Bio Innovations who talks about his journey into biotech, the challenges of drug development, and why opportunities come from unlikely places.Could you give us a brief description of yourself and what you do at CN Bio?

Coming from a microbiology and biochemistry background, with a diverse array of interesting past roles, I have a unique perspective and approach in what I do. My previous roles include genomics product manager for a large multinational company, marketing manager, product manager for a microbiological biotechnology start-up, overseeing customer relations and sales, as well as being the laboratory manager for one of the largest aquariums in the southern hemisphere!

As a product manager at CN Bio Innovations, a market-leading organ-on-chip biotech company, I am tasked with ensuring the successful launch of my product, managing the lifecycle to ascertain a driving position within the global drug development market.

Teamwork. Intriguing.Dynamic. Coordination. Research.

Upon moving to the UK from South Africa in 2016, where I was a laboratory manager in a large public aquarium, I entered the biotech field. My first product manager role was launching market-disruptive equipment related to microbiological testing (perfect with my background in microbiology and biochemistry). This linked very closely with the pharma market, and subsequent roles kept this association as a genomics product manager and now as a product manager at CN Bio Innovations, working with equipment centred within the pharma and biotechnology spectrum.

It is going to sound clichd, but every time I bring a new product to market, it is a new career highlight. Being a product ,manager means being involved in every aspect of the product development from inception to launch (and beyond). Seeing something which is a culmination of ideas, proposals, design modifications and user feedback is really a fulfilling experience. I am in the fortunate position of managing products which I truly believe will make a difference making it easy to be passionate about them!

I tend to get involved too easily, agreeing to take on more and more. I think that is why product management suits me so well I am able to be involved in many different facets of the product cycle, though I have had to train myself to delegate and not keep putting my hand up, but rather guide others where needed.

There is so much! I love being involved in bringing new technology, which I really believe will make a difference, to market. Working with diverse teams I get to learn something new every day, which is very important to me and keeps me growing. Being customer-facing is a huge boon to me. I absolutely love interacting with customers and building new relationships the interplay can be quite exhilarating.

And my team at CN Bio (of course). Our company is very close-knit, filled with people at the top of their field working together as a cohesive, caring and informal team!

The one thing I would change is accessibility to market. Organ-on-chip and microfluidic technology is still very unknown, which makes market penetration quite challenging. Though we are making a difference within the industry, I do feel that getting the technology out there and increasing exposure would benefit everyone on all levels of the industry ladder!

Outside of product management, I really enjoy marketing. Having done quite a bit of it throughout my career, it is my second passion.

Resource optimisation. In this time of remote working I think people are going to need to optimise resources such as staff, space and other resources. Combine this with a greater need for medical research and drug development at a greater pace, and you have quite a challenging environment on the horizon. But it is also an exciting frontier which leaves a lot of space for innovation which is why we at CN Bio are constantly working to improve, innovate and push the envelope.

If the Covid-19 crisis has shown us anything, it is that there are opportunities in the most unlikely places.

I think major opportunities lie in drug development and redevelopment. Being able to increase drug development efficiency, to optimise current models or test existing compounds for new applications is the wave that is building hard and fast. The pandemic has also seen companies open more to collaborations, which I feel will be the cornerstone that facilitates the greatest breakthroughs.

We at CN Bio Innovations are already collaborating with a wide variety of partners on this front from academics to some of the worlds biggest pharma companies and regulatory bodies. Being able to bring health solutions to market cheaper and faster benefits the whole world, empowering us all to achieve our full potential.

Original post:
Meet the maker: EPM talks to CN Bio's Jean-Pierre Joubert - EPM Magazine

Biochemistry

Biochemistry Analyser Market Registered 5.5% CAGR with the Market Value US$ 4700 Mn in Forecast Year 2024 – WaterCloud News

New York City, United States With the outbreak of COVID-19 in worldwide and stipulated lockdown, the healthcare sector is witnessing an unprecedented slowdown as per EY-FICCI study titled, COVID-19 impact assessment for healthcare sector and key financial measures recommendations for the sector. The study is predicated on an assessment of healthcare players within the country to assess the economic impact of the COVID-19 pandemic and provides recommendations on the fiscal stimulus measures it needs within the coming months.

The clinical use of biochemistry analyzers in measurement solutions such as latex agglutination, ion-selective potentiometry, and colorimetric & photometric testing. In addition to this, accuracy of biochemistry analyzers in analyzing blood and urine samples has benefited pathology labs and diagnostic centers across the globe. Persistence Market Research predicts that the global demand for biochemistry analyzers will continue to soar on the grounds of such factors.

A recent report published by Persistence Market Research projects that by the end of 2024, the global market for biochemistry analyzers will reach US$ 4,625.3 Mn in terms of value.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/6451

Company Profiles

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/6451

Key findings in the report cite that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins is gaining traction.

The report current values the globalbiochemistry analyzer marketat a little over US$ 3,000 Mn. During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%.

Key Research Insights from the Report include:

The global market for biochemistry analyzers represents absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024

Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patients metabolic functions

Access Full Report @ https://www.persistencemarketresearch.com/checkout/6451

Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America

Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR

Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers a cost-effective upgrade to existing product line

The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come. In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted by sales of fully-automated biochemistry analyzers.

Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR.

The report further identifies diagnostic centers as largest end-users of biochemistry analyzers in the world. On the other hand, rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together, hospitals and diagnostics centers will be responsible for procure over two-third of global biochemistry analyzers revenues through 2024.

More here:
Biochemistry Analyser Market Registered 5.5% CAGR with the Market Value US$ 4700 Mn in Forecast Year 2024 - WaterCloud News

Biochemistry

Rowan junior named a top undergrad researcher in chemistry – Rowan Today

A Rowan University student has received the prestigious Eastern Analytical Symposium Undergraduate Student Research Award for 2020.

Joshua Davis, from Swedesboro, New Jersey, is one of four students nationally recognized for their work in the field of analytical chemistry. Awardees are selected by an independent jury of experts from nominations received from the scientific community at large.

Davis was nominated and selected for his outstanding work developing novel microfluidic devices designed for both point-of-care clinical diagnostics and fundamental studies related to breast cancer metastasis. His efforts have been partially supported through a Restek Academic Support Program grant.

The award selection committee also appreciated Daviss efforts during the COVID-19 pandemic. This spring, he was part of a collaborative team of Rowan University faculty and students that created 3D-printed face masks to address a shortage of personal protective equipment for South Jerseys health care workers and emergency responders.

Davis will receive an honorarium, travel expenses to the November 2020 Eastern Analytical Symposium in Princeton, a plaque, and the opportunity to present his work at the symposium.

Rowan University President Dr. Ali Houshmand praised the College of Science & Mathematics for preparing Davis.

This is truly impressive and a testament to the high level of undergraduate research that takes place in the College, Houshmand said. Congratulations to Josh and the entire Chemistry faculty.

"For two years in a row, the Eastern Analytical Symposium has recognized a Rowan University undergraduate for research excellence, said Dr. Beena Sukumaran, Rowans vice president of research. We are so gratified to know that our students' hard work and dedication in the lab are earning the respect they deserve. Joshua Davis award exemplifies what we value at Rowan, which is the integration of undergraduate students in research."

For the past two years, Davis has been working in the laboratory of Dr. James Grinias, assistant professor in the Department of Chemistry & Biochemistry. His research focuses on how to reduce the size and cost of pumping mechanisms for analytical devices.

Traditional devices are still very large and require samples to be taken in the lab. Davis believes his research on reducing the size of microfluidic devices is important, because it enables chemical and biological analytical costs to be reduced while obtaining results similar to those found with benchtop equipment.

The thing that makes Josh special is his strong work ethic and his relentless dedication to excellence, Grinias said. He works so hard to finish just one more experiment to really make sure that his new microfluidic devices are working properly or to confirm that the data truly answers the questions he is asking.

Davis values the opportunity to do laboratory work as an undergraduate.

To do undergraduate research, in my eyes, is very important because it bridges the gap from fundamentals learned in the classroom to the application of what is being studied, Davis said. It allows you to gain the experience that you will need to solve problems in a job setting or in graduate school.

In turn, Grinias values Davis contributions in the lab.

He is technically gifted and has taught himself many engineering-related skills that we need for our research, that I myself did not possess, said Grinias. His ultimate goal is the success of the project and he will not rest until he achieves it.

In addition to this honor, Davis was named Rowan Universitys Department of Chemistry & Biochemistry winner of the American Chemical Society Undergraduate Award in Analytical Chemistry for 2020.

Davis plans to continue his research during his upcoming senior year at Rowan. After graduation, he plans to pursue graduate studies in analytical chemistry.

His true goal in the pursuit of a career in analytical chemistry is to help others, a trait I truly admire in him, said Grinias.

Davis is the second student from Rowan University to receive this award. Samuel Foster, also a member of the Grinias lab team, won the award in 2019. Foster graduated with a B.S. in Chemistry in May 2020 and will begin his graduate studies in analytical chemistry this fall at Rowan University.

The rest is here:
Rowan junior named a top undergrad researcher in chemistry - Rowan Today